This website provides the basic information about Xolair-treatment
for Asthma and safe places to buy Xolair drug. The Generic
name of Xolair is Omalizumab.
Asthma is a distressing problem afflicting approximately 5
million people in the U.S. And about 1.5 million
of that majority is deemed as having very serious asthma
problems, and of this number, half of them are proven to be
poor responders to various treatments, and their asthma has
become difficult to control. And this is a very big issue
for these million plus people, and for the different
pharmaceutical bodies. Thus Xolair a.k.a (omalizumab) has
been formulated and manufactured by Novartis, for those very
millions that desperately need another solution to their
problem. Zolair is taken inform of Xolair injection.
Xoliar has been introduced to combat all the root causes of
asthma in half of all serious cases to date. What Xoliare
does exactly is it does not treat the various
symtoms of
asthma, but it interrupts the progression of events that
encourages the physical signs, symptoms and effects of
asthma. It mainly targets the antibody IgE, this is the
antibody that is found in extra amounts in the individuals
who are sensitive to and affected by the proteins found in
animal dander, pollen, general house mites, etc.
Xolair actually binds itself to these IgE antibodies, and
proceed to block their specific actions that normally
follow, thus eventually preventing inflammation of the
bronchial tube which causes the spasms. With this
anti-inflammatory action being the key effect of the Xolar,
asthma will be at a controllable level, and that individual
may begin to become responsive to other medicines.
Enquiry
Field Marked with asterisk (*) are
mandatory
Name *
Email *
State/Country
Comments *
Xolair is a
Product of
Novartis Pharmaceuticals Corporation
Xolair
|
Asthma |
Xolair Availability |
Side
effects |
About Novartis |
Where to buy
Zolair | Related
Websites
Xolair is a PRESCRIPTION DRUG. This website doesn't
sells nor promotes Xolair. This is an independent
information site reporting on Xolair, a drug
developed by
Novartis Pharmaceuticals
Corporation.
